Autoantigen-specific memory CD4+ T cells are prevalent early in progression to Type 1 diabetes

被引:33
作者
Oling, Viveka [1 ]
Reijonen, Helena [2 ]
Simell, Olli [3 ]
Knip, Mikael [4 ,5 ,6 ]
Ilonen, Jorma [1 ,7 ]
机构
[1] Univ Turku, Immunogenet Lab, FI-20520 Turku, Finland
[2] Virginia Mason, Benaroya Res Inst, Seattle, WA 98101 USA
[3] Univ Turku, Dept Pediat, FI-20521 Turku, Finland
[4] Univ Helsinki, Hosp Children & Adolescents, FI-00029 Helsinki, Finland
[5] Univ Helsinki, Folkhalsan Res Ctr, FI-00029 Helsinki, Finland
[6] Tampere Univ Hosp, Dept Pediat, FI-33521 Tampere, Finland
[7] Univ Eastern Finland, Dept Clin Microbiol, FI-70211 Kuopio, Finland
关键词
T1D; T cells; GAD65; Insulin; GLUTAMIC-ACID DECARBOXYLASE; CLASS-II TETRAMERS; AT-RISK SUBJECTS; PERIPHERAL-BLOOD; GENERAL-POPULATION; EPITOPES; INSULIN; AUTOANTIBODIES; PREDICTION; CHILDREN;
D O I
10.1016/j.cellimm.2011.12.008
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Autoreactive CD4(+) T cells contribute to the destruction of insulin producing beta cells in Type 1 diabetes (T1D). Using MHC class II tetramers, we have analyzed the frequency of GAD65-(274-286; 555-567) and insulin-(A1-15; A6-21) specific CD4(+)T cells in 31 children with T1D, 65 multiple autoantibody-positive children and 93 HLA- and age-matched controls. In a smaller group of children T-cell responses of memory origin to the same autoantigens were investigated. We observed a higher response to GAD65 555-567 in the autoantibody-positive children than in the controls (P = 0.017). Memory T-cell responses to GAD65 555-567 were more frequent among T1D patients (P = 0.025) and autoantibody-positive (P = 0.054), while all controls were negative (n = 28). In summary, the presence of antigen experienced GAD65-specific T cells in the subjects with diabetes-associated autoimmunity is encouraging for further directions in the prediction of T1D. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:133 / 139
页数:7
相关论文
共 37 条
  • [1] Natural history of type 1 diabetes
    Achenbach, P
    Bonifacio, E
    Koczwara, K
    Ziegler, AG
    [J]. DIABETES, 2005, 54 : S25 - S31
  • [2] Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health
    Arif, S
    Tree, TI
    Astill, TP
    Tremble, JM
    Bishop, AJ
    Dayan, CM
    Roep, BO
    Peakman, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (03) : 451 - 463
  • [3] COMBINED ANALYSIS OF AUTOANTIBODIES IMPROVES PREDICTION OF IDDM IN ISLET-CELL ANTIBODY-POSITIVE RELATIVES
    BINGLEY, PJ
    CHRISTIE, MR
    BONIFACIO, E
    BONFANTI, R
    SHATTOCK, M
    FONTE, MT
    BOTTAZZO, GF
    GALE, EAM
    [J]. DIABETES, 1994, 43 (11) : 1304 - 1310
  • [4] Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects
    Danke, NA
    Yang, JB
    Greenbaum, C
    Kwok, WW
    [J]. JOURNAL OF AUTOIMMUNITY, 2005, 25 (04) : 303 - 311
  • [5] Autoreactive T cells in healthy individuals
    Danke, NA
    Koelle, DM
    Yee, C
    Beheray, S
    Kwok, WW
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (10) : 5967 - 5972
  • [6] Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes
    Di Lorenzo, T. P.
    Peakman, M.
    Roep, B. O.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 148 (01) : 1 - 16
  • [7] Predominantly recognized proinsulin T helper cell epitopes in individuals with and without islet cell autoimmunity
    Durinovic-Belló, I
    Boehm, BO
    Ziegler, AG
    [J]. JOURNAL OF AUTOIMMUNITY, 2002, 18 (01) : 55 - 66
  • [8] EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360
  • [9] Endl J, 2006, DIABETES, V55, P50, DOI 10.2337/diabetes.55.01.06.db05-0387
  • [10] Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients
    Endl, J
    Otto, H
    Jung, G
    Dreisbusch, B
    Donie, F
    Stahl, P
    Elbracht, R
    Schmitz, G
    Meinl, E
    Hummel, M
    Ziegler, AG
    Wank, R
    Schendel, DJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (10) : 2405 - 2415